Recent Advances in Biosensor Technologies for Point-of-Care Urinalysis.
Chuljin HwangWon-June LeeSu Dong KimSungjun ParkJoo-Hee KimPublished in: Biosensors (2022)
Human urine samples are non-invasive, readily available, and contain several components that can provide useful indicators of the health status of patients. Hence, urine is a desirable and important template to aid in the diagnosis of common clinical conditions. Conventional methods such as dipstick tests, urine culture, and urine microscopy are commonly used for urinalysis. Among them, the dipstick test is undoubtedly the most popular owing to its ease of use, low cost, and quick response. Despite these advantages, the dipstick test has limitations in terms of sensitivity, selectivity, reusability, and quantitative evaluation of diseases. Various biosensor technologies give it the potential for being developed into point-of-care (POC) applications by overcoming these limitations of the dipstick test. Here, we present a review of the biosensor technologies available to identify urine-based biomarkers that are typically detected by the dipstick test and discuss the present limitations and challenges that future development for their translation into POC applications for urinalysis.
Keyphrases
- loop mediated isothermal amplification
- sensitive detection
- low cost
- label free
- gold nanoparticles
- quantum dots
- high resolution
- endothelial cells
- ejection fraction
- newly diagnosed
- high throughput
- single molecule
- prognostic factors
- chronic kidney disease
- patient reported outcomes
- induced pluripotent stem cells
- climate change